⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MYGN News
Myriad Genetics Inc
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
globenewswire.com
MYGN
Global DNA Microarray Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~7% by 2034 | DelveInsight
globenewswire.com
CRSP
TMO
EDIT
LGL
SANG
PRGS
CELC
REGN
ILMN
MYGN
BIIB
DHR
ROST
QGEN
DGX
ABT
MRK
PACB
AZTA
Form 8-K
sec.gov
MYGN
Myriad Genetics Reports First Quarter 2026 Financial Results; Reiterates 2026 Financial Guidance Reflecting Ongoing Progress in the Cancer Care Continuum Business
globenewswire.com
MYGN
Myriad Genetics National Survey: 88% of Patients with Depression and/or Anxiety Would Feel More Confident with a Personalized Mental Health Care Plan
globenewswire.com
MYGN
Global Metagenomics Sequencing Market to Register Stunning Growth at a CAGR of ~13% by 2034 | DelveInsight
globenewswire.com
CRSP
TMO
RGEN
ILMN
MYGN
DHR
QGEN
DGX
PACB
AMGN
AGNC
CELC
PERI
MRK
MTX
AZTA
ProgenyHealth Announces New Appointments to Company Leadership Board and Executive Team
prnewswire.com
MYGN
Myriad Genetics to Release First Quarter 2026 Financial Results on May 5, 2026
globenewswire.com
MYGN
Myriad Genetics to Deliver Six Abstracts, Including Two Podiums, at AACR 2026
globenewswire.com
MYGN
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
globenewswire.com
MYGN